Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

This summary report looks at approaches like relaxation techniques, selective serotonin reuptake inhibitors (SSRIs), sleep and helpful thinking patterns as part of the different mental health treatments and approaches currently available.

Professor Catherine Harmer, study author, Department of Psychiatry, University of Oxford, said:

 

'Clinical trials show that SSRIs (antidepressants) can help treat anxiety and depression in young people, but they aren’t a solution for everyone. We need to start again when it comes to developing new treatments for young people and we need more research on how treatments work in this age group and how we can make them work better.' 

This publication is released alongside Insights from the Wellcome Global Monitor, a new global survey looking into people's experiences and views on mental health and science. The Global Monitor report highlights that over nine in ten people worldwide (92%) feel mental health is as or more important than physical health for overall wellbeing, with almost half (46%) saying it is more important.

Despite the high value people put on mental health, the survey found that science’s role in understanding and alleviating mental health issues seems unclear to many. Less than a third said science can explain a lot about how feelings and emotions work (27%) or can do a lot to help treat anxiety or depression (31%). In contrast, about half said science can do a lot to help treat infectious diseases (53%) or cancer (49%).  

Professor Miranda Wolpert, Director of Mental Health at Wellcome, said: 

 

'It’s clear that people around the world really value mental health but they don’t see science’s role in improving it. This is perhaps not that surprising, when we still know so little about what works for whom, and why. Science has enormous potential to improve mental health and researchers across the world are working to deepen our understanding and develop new treatment approaches. It might not be easy, but it’s within our grasp. Now is the time to go further and faster to find solutions to the problems faced by all of us.'

Read the full news story and the Wellcome Global Monitor Mental Health report

 

Similar stories

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

DPAG launches “Body, Brain, Behavior: Three Views and a Conversation” in Oxford

The Oxford Book Launch 'Body Brain Behavior - The Need For Conversations' brought together three world leading scientist authors, Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch, with Oxford's neuroscience community on Thursday 7 April 2022.

Little understood brain region linked to how we perceive pain

A new review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.